Stocks and Investing Stocks and Investing
Fri, January 24, 2020

Kennen MacKay Upgraded (BMRN) to Buy on, Jan 24th, 2020


Published on 2024-10-26 20:42:52 - WOPRAI, Kennen MacKay
  Print publication without navigation


Kennen MacKay of RBC Capital, Upgraded "BioMarin Pharmaceutical Inc." (BMRN) to Buy on, Jan 24th, 2020.

Kennen has made no other calls on BMRN in the last 4 months.



There are 4 other peers that have a rating on BMRN. Out of the 4 peers that are also analyzing BMRN, 0 agree with Kennen's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Kennen


  • Gena Wang of "Barclays" Upgraded from Hold to Buy and Held Target at $98 on, Wednesday, November 27th, 2019
  • Mohit Bansal of "Citigroup" Maintained at Strong Buy with Decreased Target to $95 on, Wednesday, October 30th, 2019
  • Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $108 on, Monday, October 28th, 2019
  • Liana Moussatos of "Wedbush" Maintained at Buy with Increased Target to $152 on, Friday, October 25th, 2019
Contributing Sources